Authors carried out a comparison study in 11 patients with malignant insulinoma, performing both GLP-1 receptor imaging (111In-labeled [Lys40(Ahx-DTPA)NH2]-exendin-4 SPECT/CT) and [68Ga]Ga-DOTATATE PET/CT. The gene discussed is GLP1R; the disease is cancer.